Cassava Sciences (MEX:SAVA) Interest Expense : MXN0.00 Mil (TTM As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Cassava Sciences Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Cassava Sciences's interest expense for the three months ended in Mar. 2024 was MXN 0.00 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2024 was MXN0.00 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Cassava Sciences's Operating Income for the three months ended in Mar. 2024 was MXN -330.83 Mil. Cassava Sciences's Interest Expense for the three months ended in Mar. 2024 was MXN 0.00 Mil. Cassava Sciences has no long-term debt ⁽¹⁾. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

(1) Note: An indication of "no long-term debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

Cassava Sciences Interest Expense Historical Data

The historical data trend for Cassava Sciences's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cassava Sciences Interest Expense Chart

Cassava Sciences Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Interest Expense

Get a 7-Day Free Trial

Cassava Sciences Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Interest Expense	Get a 7-Day Free Trial															-	-	-	-	-

Cassava Sciences Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN0.00 Mil.

Cassava Sciences (MEX:SAVA) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Cassava Sciences's Interest Expense for the three months ended in Mar. 2024 was MXN0.00 Mil. Its Operating Income for the three months ended in Mar. 2024 was MXN-330.83 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2024 was MXN0.00 Mil.

Cassava Sciences's Interest Coverage for the quarter that ended in Mar. 2024 is calculated as

Cassava Sciences had no long-term debt ⁽¹⁾.

The higher the ratio, the stronger the company's financial strength is.

Good Sign:

Cassava Sciences Inc has no debt.

Cassava Sciences (MEX:SAVA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cassava Sciences Inc (MEX:SAVA) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

SAVA:USA PX91:Germany

Address

6801 N. Capital of Texas Highway, Suite 300, Building 1, Austin, TX, USA, 78731

Website

https://www.cassavasciences.com

Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnostic product candidate is called SavaDx, and it is a novel way to detect the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms.